eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy

eagle-i ID

http://hawaii.eagle-i.net/i/00000130-dd87-5552-9953-50a980000000

Resource Type

  1. Clinical trial

Properties

  1. ClinicalTrials.gov url
    http://www.clinicaltrials.gov/ct2/show/NCT00006227?term=GOG-0187&rank=1
  2. Intervention
    Paclitaxel
  3. Additional Topic(s)
    Inhibin
  4. Resource Description
    The purpose of this study is to estimate the probability of clinical response and toxicity of paclitaxel as second-line chemotherapy in measurable disease patients with malignant tumors of the ovarian stroma, and to evaluate the value of inhibin for predicting response.
  5. Contact
    Berenberg, Jeffrey
  6. PI
    Berenberg, Jeffrey
  7. Topic
    ovarian cancer
  8. Study Population
    Patients with histologically confirmed ovarian stromal tumor [granulosa cell tumor, granulosa cell-theca cell tumor, Sertoli-Leydig cell tumor (androblastoma), steroid (lipid) cell tumor, gynandroblastoma, unclassified sex cord stromal tumor, sex cord tumor with annular tubules], and meeting other disease and treatment related criteria.
  9. Funded by
    Gynecologic Oncology Group
  10. Phase
    Phase 2 clinical trial
  11. Performed by
    Clinical Protocol & Data Management Shared Resource
 
RDFRDF
 
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016